In our study, the de-regulation of both BCL-2 and Beclin 1 after TG10129 treatment implied that TG10129 might function as not only a JAK2 inhibitor to reduce the proliferation of T-ALL cells but also as a regulator of apoptosis and autophagy. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.